Management Team

Pei-Jiun Chen, Ph.D.

Chairman/CEO and President
- Ph.D. in Biology, University of Michigan, USA
- B.S. in Zoology, NTU, TW
- CEO of TPG Biologics, Inc.
- Sr. Researcher of AltruBio
- More than 20 years experience in Biologics development, Business development and company management.
Wei-I Chou, Ph.D.

Pharmaceutical Development Associate Vice President
- Ph.D. in Life Science, NTHU, TW
- RD Manager of Reber Genetics,Thevax Genetics Vaccine
- More than 10 years experience in Gene recombinant protein and vaccine development, Process development and scale up, methods for assessing the biological activity of drugs development.
Vincent Liang

Administrative Management Associate Vice President
- Master of Information Management, Chung Yuan Christian University, Taiwan
- Senior Associate Vice President, KADOKAWA TAIWAN CO.,LTD, Taiwan、Senior Consultant, Ares International Co., Taiwan…
- More than 20 years of information technology services, corporate business strategy formulation, corporate process diagnosis/reengineering, information system architecture planning and development...etc.
Liru Yeh

Finance & Accounting, Associate Vice President
- National Sun Yat-Sen University MBA, Department of Finance
- Integral Group, Investment Senior Vice President
- KGI Securities Company, Vice President , Capital Market Department
- TWI Pharmaceutical Inc. & TWI Biotechnology Inc., Executive Director, Finance, Accounting & Operation
Attila Huang

Director of Project Management
- Master of Medicine, Chung Shan Medical University
- GE Healthcare Product Specialist
- Director of GMP Plant 1 of Mycenax
- Has more than 20 years of experience in biopharmaceutical industry development, GMP manufacturing, and CDMO services. Participated in and promoted Mycenax's first drug development to certification and launch
Allen Lin, Ph.D.

Quality Assurance Senior Manager
- PhD in Biochemical Science, National Taiwan University, Taiwan
- Head of Quality Assurance, Savior Lifetec Corporation
- 10+ years of professional experienced in cGMP compliance, quality management, aseptic processing, and validation
- Profound experience in GMP and Pre-Approval Inspection from renowned regulatory agencies including US FDA, UK MHRA, Health Canada, Japan PMDA, Brazil ANVISA, and Korea MFDS
Eric Wen

Quality Control Senior Manager
- Master in Institute of Medicine, CSMU, TW
- WuXi Biologics QC Head (Hebei site)
- Over 17 years experience in QC across different types of biologics
- Experiences in regulatory inspection from FDA, EMA, TFDA and MFDS
Pank Tsai

Director GMP Plant 1
- M.Sc. in Institute of Molecular Medicine, NTHU
- MFG Assistant Manager at Formosa Laboratories
- Production Supervisor at Impax Laboratories
Kung Jen Chang

Manager of manufacturing department, plant 2
- Master of Science in IBS, National Taiwan University, Taiwan
- Researcher, downstream development group, DCB-Biopharmaceutical Pilot Plant
- Leader of biological downstream development group, Mycenax Manager of manufacturing department of GMP Plant 2, Mycenax
- Specializing in biological downstream process development and scale-up design, GMP manufacturing, facility design and construction
Peggy Tseng, Ph.D.

Pharmaceutical Development Senior Manager
- Ph.D. in Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taiwan
- R&D Director and Production Manager Director of BO HUI Biotech Co., Ltd.
- Lab Director and R&D Senior Manager of HealthBanks Biotech Co., Ltd
- 15 years of CGT product development, scalable process development, CMC strategy and management of cell processing center compliance with GTP
Jih-Huong Guo

Pharmaceutical Development Manager
- M.S. in Microbiology, National Taiwan University
- Former Director of Upstream Process Development at TPG Biologics and Lumosa Therapeutics
- 15+ years of R&D and leadership experience in CRO/CDMO
- Expert in process development and scale-up strategies for diverse protein molecules
- Led teams to establish advanced platforms such as NaxLEAP and perfusion technologies
- Developed processes for allogeneic cell therapies, including CAR-NK92 and γδT cell products
Jheng-Liang Yao

Pharmaceutical Development Manager
- Master of Science in IBS, National Taiwan University, Taiwan
- Director, TPG Biologics, Inc., Taiwan
- 15 years of experiences in downstream processing and protein characterization for various types (e.g., mAb, fusion protein, vaccine, plasmid, and ADC) of biopharmaceutical products from early development to clinical trial stage
Albert Liao, Ph.D.

Manufacturing Science and Technology Department Manager
- Ph.D. and Postdoctoral Fellow in Institute of Biochemistry and Molecular Biology, National Yang-Ming University, Taiwan
- Process Development and GMP Manufacturing Supervisor of Mycenax Biotech
- 10 years experience in biopharmaceutical process development and GMP manufacturing
- 20+ CDMO project execution (process development, process transfer, process characterization and process validation)
- Several official inspections (Health Canada, PMDA, MFDS) and QP site audits experience
Hui-Ju (Judy) Yang Ph.D.

Pharmaceutical Development Associate Manager
- Ph.D. in Molecular and Cell Biology, Stony Brook University, USA
- Research Fellow, Osaka University, Japan
- Principal Investigator, National Health Research Institutes, Taiwan
- 20 years of basic scientific research, CMC experiences in Phase I to III clinical trials for biologics, lead +20 CDMO projects